↓ Skip to main content

Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer

Overview of attention for article published in Frontiers in oncology, August 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer
Published in
Frontiers in oncology, August 2021
DOI 10.3389/fonc.2021.708039
Pubmed ID
Authors

Masaaki Ito, Takaki Hiwasa, Yoko Oshima, Satoshi Yajima, Takashi Suzuki, Tatsuki Nanami, Makoto Sumazaki, Fumiaki Shiratori, Kimihiko Funahashi, Shu-Yang Li, Yasuo Iwadate, Hiroki Yamagata, Byambasteren Jambaljav, Minoru Takemoto, Koutaro Yokote, Hirotaka Takizawa, Hideaki Shimada

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 17%
Other 3 13%
Student > Ph. D. Student 2 9%
Student > Master 2 9%
Unspecified 1 4%
Other 1 4%
Unknown 10 43%
Readers by discipline Count As %
Medicine and Dentistry 5 22%
Nursing and Health Professions 2 9%
Arts and Humanities 1 4%
Unspecified 1 4%
Biochemistry, Genetics and Molecular Biology 1 4%
Other 2 9%
Unknown 11 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 September 2021.
All research outputs
#21,307,042
of 26,163,973 outputs
Outputs from Frontiers in oncology
#11,634
of 22,913 outputs
Outputs of similar age
#333,126
of 438,376 outputs
Outputs of similar age from Frontiers in oncology
#637
of 1,367 outputs
Altmetric has tracked 26,163,973 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,913 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,376 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,367 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.